Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,475 | 30,253 | -302,139 | -220,408 | -141,181 |
| Depreciation Amortization | 11,327 | 5,921 | 7,531 | 4,762 | 3,267 |
| Income taxes - deferred | N/A | N/A | -16,246 | N/A | N/A |
| Accounts receivable | -12,253 | 1,501 | -5,172 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,376 | -1,317 | N/A | 3,879 | 6,353 |
| Other Working Capital | -28,147 | -19,222 | -3,985 | 3,584 | 1,198 |
| Other Operating Activity | -115,384 | -106,614 | 66,168 | 36,163 | 20,336 |
| Operating Cash Flow | $-165,556 | $-89,478 | $-253,843 | $-172,020 | $-110,027 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -291,567 | -200,553 | 201,079 | -15 | -30,836 |
| PPE Investments | -1,852 | -475 | -2,793 | -1,894 | -861 |
| Net Acquisitions | N/A | N/A | -142,804 | N/A | N/A |
| Other Investing Activity | 170,322 | 130,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-123,097 | $-71,028 | $55,482 | $-1,909 | $-31,697 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -4,944 | N/A | N/A |
| Common Stock Issued | 299,587 | 286,419 | 141,211 | 71,828 | 70,495 |
| Financing Cash Flow | $299,587 | $286,419 | $136,267 | $71,828 | $70,495 |
| Exchange Rate Effect | -647 | 249 | 528 | 167 | -361 |
| Beginning Cash Position | 103,041 | 103,041 | 164,607 | 164,607 | 164,607 |
| End Cash Position | 113,328 | 229,203 | 103,041 | 62,673 | 93,017 |
| Net Cash Flow | $10,287 | $126,162 | $-61,566 | $-101,934 | $-71,590 |
| Free Cash Flow | |||||
| Operating Cash Flow | -165,556 | -89,478 | -253,843 | -172,020 | -110,027 |
| Capital Expenditure | -1,852 | -475 | -2,793 | -1,894 | -861 |
| Free Cash Flow | -167,408 | -89,953 | -256,636 | -173,914 | -110,888 |